NCT07108153 Phase 2 Completed
Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta Study sponsor: Sionna Therapeutics Inc. · SION
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2026-06-25 Actual
Enrollment · participants 15 Actual
Source updated 2026-09-10 Last update listed in the registry record
Version history
Changes to this trial Last 12 months Posted 2026-09-10 · 5 fields changed
Participant count type Recorded edit − Previous value Estimated
Enrollment · participant count Recorded edit − Previous value count: 16; type: ESTIMATED
+ Updated value count: 15; type: ACTUAL
Completion date type Recorded edit − Previous value Estimated
Primary completion date Recorded edit + Updated value 2026-06-25
Recruitment status Recorded edit − Previous value Active not recruiting
Check registry source Posted 2026-05-06 · 1 field changed
Recruitment status Recorded edit − Previous value Recruiting
+ Updated value Active not recruiting
Check registry source Posted 2025-10-24 · 1 field changed
Recruitment status Recorded edit − Previous value Not yet recruiting
+ Updated value Recruiting
Check registry source This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial